<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="22155">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02818413</url>
  </required_header>
  <id_info>
    <org_study_id>16-001515</org_study_id>
    <nct_id>NCT02818413</nct_id>
  </id_info>
  <brief_title>Stool Microbiome, Pathogens, and Infectious Agents Among Olympic and Elite Athletes</brief_title>
  <acronym>TRMC-Bio</acronym>
  <official_title>TRMC-Bio &quot;Molecular Profiling of Gut Microbiome, Microbiome Metabolome, Serum Chemistry, and Metabolism-Associated SNPs in Elite Athletes&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Thorne Research Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research is being done to investigate fecal microbiome and metabolome as well as serum
      analytes and single nucleotide polymorphisms in Olympic athletes in comparison with other
      elite athletes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Olympic athletes, non-Olympic elite athletes, and other active adults may have genetic and
      metabolic profiles that are unique. These profiles may contribute to the caliber of their
      athletic performance, and they may provide keys to understanding select genetic and
      metabolic conditions.

      Therefore, the specific aims of this project are as follows:

        -  Specific Aim 1: Characterize the fecal microbial communities in athletes participating
           in the summer 2016 games and in athletes not participating in the Olympic games

        -  Specific Aim 2: Characterize the fecal microbiome metabolome (untargeted) in athletes
           participating in the summer 2016 games and in athletes not participating in the Olympic
           games

        -  Specific Aim 3: Characterize selected serum analytes and single nucleotide
           polymorphisms (SNPs) of elite athletes participating in the Summer 2016 games and in
           athletes not participating in the Olympic games, via serum and saliva analyses,
           respectively

        -  Specific Aim 4: Retain specimens from Olympic athletes participating in the summer 2016
           games and in athletes not participating in the Olympic games for future research

        -  Specific Aim 7: Examine for the presence of Zika virus RNA in study participants who
           exhibit symptoms

      Stool, urine, and blood specimens will be collected to study the stool metabolome, as well
      as serum analytes and single nucleotide polymorphisms, and the nature and extent of exposure
      to pathogens and infectious agents. These will be compared between Olympic athletes and
      other non-Olympic elite athletes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Baseline identification of microbial community present in stool</measure>
    <time_frame>Approximately 1 week after collection of stool sample</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Athletic Performance</condition>
  <arm_group>
    <arm_group_label>U.S. Olympic Team and elite athletes</arm_group_label>
    <description>Biospecimens will be collected from and questionnaires will be administered to U.S. Olympic team members and other elite athletes</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biospecimen collection and questionnaires</intervention_name>
    <description>Biospecimen collection and questionnaires</description>
    <arm_group_label>U.S. Olympic Team and elite athletes</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Stool samples will be retained for future research
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Members of the U.S. Olympic teams and other elite athletes
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Member of the Summer 2016 U.S. Olympic team and/or other elite athlete

          -  English speaking

          -  Willing to provide informed consent and biospecimens

          -  Willing to complete questionnaires regarding normal bowel habits and general health

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brent A. Bauer, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lori A. Bergstrom, RN</last_name>
    <phone>507-538-1887</phone>
    <email>bergstrom.lori@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Brent A. Bauer, M.D.</last_name>
    <phone>507-284-2511</phone>
    <email>bauer.brent@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lori A. Bergstrom, RN</last_name>
      <phone>507-538-1887</phone>
      <email>bergstrom.lori@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Karrie M. Fursa</last_name>
      <phone>507-266-2218</phone>
      <email>fursa.karrie@mayo.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Brent A Bauer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 7, 2016</lastchanged_date>
  <firstreceived_date>June 28, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Brent A. Bauer</investigator_full_name>
    <investigator_title>Professor of Medicine, General Internal Medicine</investigator_title>
  </responsible_party>
  <keyword>Stool microbiome</keyword>
  <keyword>Stool metabolome</keyword>
  <keyword>Single nucleotide polymorphisms</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
